🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/05/2003 | 35,00 | 39,11 | 34,85 | 37,39 | +6,84% | 12,19% | 882.024 |
| 12/05/2003 | 33,20 | 35,00 | 32,00 | 35,00 | +4,00% | 9,02% | 289.448 |
| 09/05/2003 | 34,44 | 34,66 | 33,16 | 33,65 | -1,86% | 4,35% | 195.806 |
| 08/05/2003 | 35,48 | 36,46 | 33,72 | 34,29 | -2,97% | 7,70% | 160.407 |
| 07/05/2003 | 36,46 | 37,06 | 35,07 | 35,33 | -3,38% | 5,44% | 197.623 |
| 06/05/2003 | 36,49 | 38,14 | 36,19 | 36,57 | +0,31% | 5,33% | 334.680 |
| 05/05/2003 | 35,30 | 36,61 | 35,00 | 36,46 | +4,73% | 4,56% | 193.482 |
| 02/05/2003 | 34,47 | 36,49 | 33,69 | 34,81 | +0,54% | 8,14% | 192.066 |
| 01/05/2003 | 33,31 | 35,52 | 32,56 | 34,62 | +3,82% | 8,88% | 207.428 |
| 30/04/2003 | 34,55 | 35,33 | 33,24 | 33,35 | -3,68% | 6,07% | 256.614 |
| 29/04/2003 | 33,76 | 34,96 | 32,79 | 34,62 | +2,10% | 6,43% | 272.857 |
| 28/04/2003 | 29,98 | 33,99 | 29,91 | 33,91 | +13,25% | 13,61% | 337.057 |
| 25/04/2003 | 31,18 | 31,18 | 29,76 | 29,94 | +2,56% | 4,56% | 188.433 |
| 24/04/2003 | 28,52 | 30,02 | 28,37 | 29,20 | -5,11% | 5,77% | 282.422 |
| 23/04/2003 | 30,17 | 30,80 | 29,57 | 30,77 | +2,11% | 4,09% | 155.117 |
| 22/04/2003 | 28,63 | 30,39 | 28,63 | 30,13 | +4,68% | 6,14% | 190.330 |
| 21/04/2003 | 29,38 | 29,38 | 28,63 | 28,78 | -1,41% | 2,55% | 77.265 |
| 17/04/2003 | 28,82 | 29,38 | 28,18 | 29,20 | +1,30% | 4,16% | 79.749 |
| 16/04/2003 | 28,90 | 29,08 | 28,48 | 28,82 | -0,26% | 2,07% | 73.070 |
| 15/04/2003 | 28,78 | 29,01 | 28,45 | 28,90 | +1,45% | 1,95% | 102.539 |
| 14/04/2003 | 28,33 | 29,08 | 27,96 | 28,48 | +0,79% | 3,96% | 67.753 |
| 11/04/2003 | 28,67 | 28,93 | 28,26 | 28,26 | -1,95% | 2,35% | 101.924 |
| 10/04/2003 | 30,06 | 30,09 | 28,63 | 28,82 | -3,75% | 4,86% | 263.239 |
| 09/04/2003 | 30,77 | 32,71 | 29,94 | 29,94 | -3,03% | 9,00% | 392.254 |
| 08/04/2003 | 29,42 | 30,88 | 29,12 | 30,88 | +4,70% | 5,98% | 300.856 |
| 07/04/2003 | 30,77 | 31,78 | 29,01 | 29,49 | -0,88% | 9,00% | 246.408 |
| 04/04/2003 | 28,86 | 29,98 | 28,11 | 29,76 | +3,52% | 6,49% | 310.608 |
| 03/04/2003 | 24,89 | 29,49 | 24,70 | 28,75 | +16,19% | 19,25% | 792.550 |
| 02/04/2003 | 24,03 | 25,12 | 23,58 | 24,74 | +4,26% | 6,39% | 153.674 |
| 01/04/2003 | 24,33 | 24,33 | 23,39 | 23,73 | -2,31% | 3,85% | 143.816 |